PofoliaShared via Pofolia

The Journal of Clinical Endocrinology & Metabolism· 2026Q1

12,13-diHOME is increased during targeted temperature management and correlates with survival after cardiac arrest resuscitation

Carolina Cora, Teresa May, Breanna Page, Rika Goto et al.

Short summary

Circulating 12,13-diHOME levels, a biomarker for brown adipose tissue (BAT) activity, are elevated in some cardiac arrest patients undergoing targeted temperature management (TTM) and correlate with improved survival.

AI-generated from the title and abstract; the full text is not read.

Key points

  • 12,13-diHOME levels increased in cardiac arrest patients treated with TTM at 33°C.
  • Elevated 12,13-diHOME correlated positively with favorable outcomes and survival.
  • 12,13-diHOME levels peaked between 12-48 hours and decreased by 7 days.
  • Higher 12,13-diHOME was linked to a specific phospholipid signature and altered neutrophil maturation.

AI-generated from the title and abstract; the full text is not read.

Abstract

CONTEXT: Trials of targeted temperature management (TTM) after cardiac arrest (CA) have had conflicting results. Brown adipose tissue (BAT) is a thermogenic organ activated by cold temperature to regulate body temperature, systemic metabolism and the immune system. Approximately 10-30% of adult patients have BAT and this heterogeneity may explain variable treatment to TTM. OBJECTIVE: This study sought to measure differences in outcome, metabolic and immune activation between patients treated with TTM following CA with varying BAT activity, measured through BAT-associated lipid 12,13-diHOME concentrations in circulation. DESIGN: BAT biomarker 12,13-diHOME was quantified using liquid chromatography-mass spectrometry (LC-MS) on plasma from 74 patients at various time points starting at 6 hours and up until 7 days after return of spontaneous circulation (ROSC). Additionally, circulating glucose, C-peptide and fatty acids were measured by glucometer, ELISA and LC-MS, respectively. Peripheral blood mononuclear cells were analyzed by flow cytometry. RESULTS: 12,13-diHOME was increased in patients treated with TTM at 33°C and positively correlated with favorable outcomes. 12,13-diHOME levels peaked in the first 12 to 48 hours and decreased below the first post-ROSC level by 7 days. Glucose homeostasis was not associated with 12,13-diHOME levels. In a subset of patients, we could detect a specific phospholipid signature in patients with higher 12,13-diHOME. Patients with higher 12,13-diHOME also had increased mature neutrophils and lower immature neutrophils. CONCLUSIONS: Circulating 12,13-diHOME levels are increased in some patients undergoing targeted temperature management after cardiac arrest, which may be indicative of increased BAT activity. 12,13-diHOME is associated with survival, alterations of phospholipid metabolism, and a profile of less activated immune system. BAT may mediate the effects of temperature management on outcome after cardiac arrest.

The authors' abstract, as published at the source. The Journal of Clinical Endocrinology & Metabolism, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Emergency Medicine

Emergency MedicineMedicine